Sweden · Delayed Price · Currency is SEK Spermosens AB Statistics
Total Valuation
Spermosens AB has a market cap or net worth of SEK 20.31 million. The enterprise value is 11.24 million.
| Market Cap | 20.31M |
| Enterprise Value | 11.24M |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Spermosens AB has 3.17 billion shares outstanding. The number of shares has increased by 1,309.32% in one year.
| Current Share Class | 3.17B |
| Shares Outstanding | 3.17B |
| Shares Change (YoY) | +1,309.32% |
| Shares Change (QoQ) | +67.55% |
| Owned by Insiders (%) | 15.67% |
| Owned by Institutions (%) | 22.12% |
| Float | 2.52B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.18 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 67.07
| Current Ratio | 67.07 |
| Quick Ratio | 67.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -100.56 |
Financial Efficiency
Return on equity (ROE) is -33.80% and return on invested capital (ROIC) is -20.69%.
| Return on Equity (ROE) | -33.80% |
| Return on Assets (ROA) | -19.50% |
| Return on Invested Capital (ROIC) | -20.69% |
| Return on Capital Employed (ROCE) | -26.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.39M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.24% in the last 52 weeks. The beta is -0.24, so Spermosens AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.24 |
| 52-Week Price Change | -52.24% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 50.20 |
| Average Volume (20 Days) | 4,653,143 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.45M |
| Pretax Income | -9.55M |
| Net Income | -9.55M |
| EBITDA | -9.28M |
| EBIT | -9.45M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 9.07 million in cash and n/a in debt, giving a net cash position of 9.07 million or 0.00 per share.
| Cash & Cash Equivalents | 9.07M |
| Total Debt | n/a |
| Net Cash | 9.07M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 34.52M |
| Book Value Per Share | 0.01 |
| Working Capital | 9.71M |
Cash Flow
| Operating Cash Flow | -3.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Spermosens AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,309.32% |
| Shareholder Yield | -1,309.32% |
| Earnings Yield | -47.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |